Catheryn D Wilson Selected Research

Catheryn D Wilson Research Topics

2	Seizures (Absence Seizure) 10/2022 - 01/2018
2	Hypothermia 01/2022 - 01/2018
2	Psychotic Disorders (Schizoaffective Disorder) 02/2018 - 01/2018
1	Tremor (Tremors) 01/2022
1	Opioid-Related Disorders (Opiate Addiction) 01/2019
1	Substance-Related Disorders (Drug Abuse) 11/2018
1	Marijuana Use 02/2018
1	Schizophrenia (Dementia Praecox) 02/2018
1	Chest Pain (Chest Pains) 01/2018
1	Dizziness (Lightheadedness) 12/2017
1	Neuralgia (Stump Neuralgia) 12/2017
1	Hyperalgesia 12/2017

4	CannabinoidsIBA 01/2022 - 01/2018
2	N- (1- amino- 3- methyl- 1- oxobutan- 2- yl)- 1- (5- fluoropentyl)- 1H- indazole- 3- carboxamideIBA 10/2022 - 01/2022
2	5-F-ADB-PINACAIBA 10/2022 - 01/2022
2	1-pentyl-3-(1-naphthoyl)indoleIBA 10/2022 - 01/2022
2	N- (1- amino- 3- methyl- 1- oxobutan- 2- yl)- 1- pentyl- 1H- indazole- 3- carboxamideIBA 10/2022 - 01/2018
2	RimonabantIBA 01/2022 - 12/2017
1	Cannabinoid Receptor AgonistsIBA 10/2022
1	ConvulsantsIBA 10/2022
1	norbuprenorphineIBA 01/2019
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2019
1	Naltrexone (ReVia)FDA LinkGeneric 01/2019
1	Opioid Analgesics (Opioids)IBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 02/2018
1	Serotonin (5 Hydroxytryptamine)IBA 02/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2018
1	Glutamic Acid (Glutamate)FDA Link 02/2018
1	EndocannabinoidsIBA 02/2018
1	Analgesics (Analgesic Drugs)IBA 12/2017
1	Gabapentin (Neurontin)FDA LinkGeneric 12/2017

1	Drug Therapy (Chemotherapy) 11/2018
1	Therapeutics 02/2018